These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 20954365)

  • 21. Single dose of tiotropium improves the 6-minute walk distance in chronic obstructive pulmonary disease.
    Okudan N; Gök M; Gökbel H; Süerdem M
    Lung; 2006; 184(4):201-4. PubMed ID: 17006746
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study.
    Vogelmeier C; Kardos P; Harari S; Gans SJ; Stenglein S; Thirlwell J
    Respir Med; 2008 Nov; 102(11):1511-20. PubMed ID: 18804362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized study of tiotropium Respimat Soft Mist inhaler vs. ipratropium pMDI in COPD.
    Voshaar T; Lapidus R; Maleki-Yazdi R; Timmer W; Rubin E; Lowe L; Bateman E
    Respir Med; 2008 Jan; 102(1):32-41. PubMed ID: 17996436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A randomized, double-blind, placebo-control study of once-daily inhaled tiotropium in chronic obstructive pulmonary disease].
    Yin KS; Zhang DP; Shi Y; Sun LH; Min R; Xiao YL; Xia XR; Tan Y; Fu WZ
    Zhonghua Jie He He Hu Xi Za Zhi; 2010 Jul; 33(7):519-23. PubMed ID: 20979799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchodilator response to formoterol after regular tiotropium or to tiotropium after regular formoterol in COPD patients.
    Cazzola M; Noschese P; Salzillo A; De Giglio C; D'Amato G; Matera MG
    Respir Med; 2005 May; 99(5):524-8. PubMed ID: 15823447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tiotropium in COPD patients not previously receiving maintenance respiratory medications.
    Adams SG; Anzueto A; Briggs DD; Menjoge SS; Kesten S
    Respir Med; 2006 Sep; 100(9):1495-503. PubMed ID: 16698259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
    Buhl R; Dunn LJ; Disdier C; Lassen C; Amos C; Henley M; Kramer B;
    Eur Respir J; 2011 Oct; 38(4):797-803. PubMed ID: 21622587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium Respimat® improves physical functioning in chronic obstructive pulmonary disease.
    Rau-Berger H; Mitfessel H; Glaab T
    Int J Chron Obstruct Pulmon Dis; 2010 Oct; 5():367-73. PubMed ID: 21103403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Onset and duration of action of formoterol and tiotropium in patients with moderate to severe COPD.
    Richter K; Stenglein S; Mücke M; Sieder C; Schmidtmann S; Harnest U; Weidinger G; Magnussen H
    Respiration; 2006; 73(4):414-9. PubMed ID: 16534180
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Theoretical and clinical aspects of tiotropium application as a first line therapy in stable state of all stages of chronic obstructive pulmonary disease].
    Chazan R
    Pol Merkur Lekarski; 2011 Nov; 31(185):292-8. PubMed ID: 22299532
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tiotropium bromide: a new long-acting bronchodilator for the treatment of chronic obstructive pulmonary disease.
    Koumis T; Samuel S
    Clin Ther; 2005 Apr; 27(4):377-92. PubMed ID: 15922812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of inhaled anticholinergic drugs (tiotropium bromide) on asthma patients with persistent obstructive ventilatory impairment].
    Nogami H; Honjo S; Iwanaga T
    Arerugi; 2012 Nov; 61(11):1675-82. PubMed ID: 23328224
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tiotropium: a potential replacement for ipratropium in patients with COPD.
    Shukla VK
    Issues Emerg Health Technol; 2002 Jul; (35):1-4. PubMed ID: 12195603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mortality in the 4-year trial of tiotropium (UPLIFT) in patients with chronic obstructive pulmonary disease.
    Celli B; Decramer M; Kesten S; Liu D; Mehra S; Tashkin DP;
    Am J Respir Crit Care Med; 2009 Nov; 180(10):948-55. PubMed ID: 19729663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Safety of tiotropium therapy in chronic obstructive lung diseases (COPD)].
    Osztovits J; Fehér J
    Orv Hetil; 2010 May; 151(18):749-50. PubMed ID: 20410002
    [No Abstract]   [Full Text] [Related]  

  • 36. Safety of tiotropium through the Handihaler: why did meta-analyses and database studies appear to give a false alarm?
    Barnes NC; Jones PW; Davis KJ
    Thorax; 2014 Jun; 69(6):598-9. PubMed ID: 24550061
    [No Abstract]   [Full Text] [Related]  

  • 37. Inhaled anticholinergic drugs and risk of acute urinary retention.
    Afonso AS; Verhamme KM; Stricker BH; Sturkenboom MC; Brusselle GG
    BJU Int; 2011 Apr; 107(8):1265-72. PubMed ID: 20880196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.
    van Noord JA; Aumann JL; Janssens E; Smeets JJ; Verhaert J; Disse B; Mueller A; Cornelissen PJ
    Eur Respir J; 2005 Aug; 26(2):214-22. PubMed ID: 16055868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tiotropium versus salmeterol for the prevention of exacerbations of COPD.
    Vogelmeier C; Hederer B; Glaab T; Schmidt H; Rutten-van Mölken MP; Beeh KM; Rabe KF; Fabbri LM;
    N Engl J Med; 2011 Mar; 364(12):1093-1103. PubMed ID: 21428765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
    Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
    Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.